Illinois Review: Healthcare Reform, from Stents to STAT: "On Friday, January 8, a news story announced 'Abbott Laboratories and Boston Scientific Stent Gets OK for Japan Market' (see Crain's Chicago Business).
Abbott's product, the Xience V, is described as a wire mesh tube, used to keep arteries open after being cleared of plaque. It's coated with Everolimus, a drug which prevents scar tissue from reclosing the artery. Neat, huh?
Good news for Chicago's north suburban star Abbott Labs... good news for their employees and investors, and good news for the 200,000 patients per year in Japan who now have this splendid option for their coronary artery surgeries, thanks to American ingenuity and investment."
No comments:
Post a Comment
Spamming will be removed.
Due to spamming. Comments need to be moderated. Your post will appear after moderated regardless of your views as long as they are not abusive in nature. Consistent abusive posters will not be viewed but deleted.
Note: Only a member of this blog may post a comment.